# EDGAR Filing Document

**Accession Number:** 0001728328
**File Stem:** 0000000000-26-003031
**Filing Date:** 2026-3
**Character Count:** 2186
**Document Hash:** f9e30962260e482b8d9802125eb4cbe9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-26-003031.hdr.sgml**: 20260505

**ACCESSION NUMBER**: 0000000000-26-003031

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260325

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** InMed Pharmaceuticals Inc.
- **CENTRAL INDEX KEY:** 0001728328
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-294503

**BUSINESS ADDRESS:**
- **STREET 1:** 1445-885 WEST GEORGIA ST.
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V6C 3E8
- **BUSINESS PHONE:** (604) 669-7207

**MAIL ADDRESS:**
- **STREET 1:** 1445-885 WEST GEORGIA ST.
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V6C 3E8
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001213900-26-032416

## Text-Extract

```

                                                           March 25, 2026

Eric Adams
Chief Executive Officer
InMed Pharmaceuticals Inc.
Suite 1445     885 West Georgia St.
Vancouver, British Columbia
Canada V6C 3E8

       Re: InMed Pharmaceuticals Inc.
           Registration Statement on Form S-3
           Filed March 20, 2026
           File No. 333-294503
Dear Eric Adams:

       This is to advise you that we have not reviewed and will not review your
registration
statement.

        Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

       Please contact Tyler Howes at 202-551-3370 with any questions.

                                                           Sincerely,

                                                           Division of
Corporation Finance
                                                           Office of Life
Sciences
cc:    Scott Saks, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._